Advances in drug development. BRAF validation in melanoma.
Flaherty
Keith
K
Massachusetts General Hospital, Boston, MA 02114, USA.
D006801:Humans; D008545:Melanoma / Q000188:drug therapy / Q000235:genetics*; D009154:Mutation; D048493:Proto-Oncogene Proteins B-raf / Q000037:antagonists & inhibitors / Q000235:genetics*
C482119:BRAF protein, human; D048493:Proto-Oncogene Proteins B-raf